ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,471Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 262

$735K Total Retail Price of All Prescriptions

Rank: 5 out of 262

361 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 6,988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 424 318 1 2
SIMVASTATIN 383 313 2 1
METFORMIN HCL 319 287 3 9
FUROSEMIDE 226 197 4 4
AMLODIPINE BESYLATE 215 210 5 6
ZOLPIDEM TARTRATE 157 112 6 26
HYDROCHLOROTHIAZIDE 154 137 7 7
HYDROCODONE-ACETAMINOPHEN 153 149 S3 8 15
MIRTAZAPINE 140 106 9 35
OMEPRAZOLE 137 114 10 5
SERTRALINE HCL 136 133 11 14
METOPROLOL SUCCINATE 119 116 12 11
GABAPENTIN 103 84 13 19
CRESTOR 103 100 13 30
EVISTA 95 78 15 73
POTASSIUM CHLORIDE 93 81 16 10
FLUOXETINE HCL 93 75 16 46
WARFARIN SODIUM 87 73 18 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 59 19 24
DONEPEZIL HCL 80 57 20 23
NAMENDA 79 68 21 37
PAROXETINE HCL 78 55 22 56
NEXIUM 78 67 22 57
METOPROLOL TARTRATE 76 75 24 8
CELEBREX 73 71 25 91
GLIMEPIRIDE 73 73 25 45
LISINOPRIL 73 71 25 3
LANTUS SOLOSTAR 70 52 28 49
LOSARTAN POTASSIUM 70 69 28 17
TRAMADOL HCL 69 43 30 18
TAMSULOSIN HCL 69 68 30 25
ALLOPURINOL 64 64 32 22
ISOSORBIDE MONONITRATE ER 64 61 32 33
PRAVASTATIN SODIUM 62 62 34 41
PANTOPRAZOLE SODIUM 61 61 35 52
PROPRANOLOL HCL 52 49 36 82
CARVEDILOL 52 52 36 31
CIPROFLOXACIN HCL 52 45 36 55
ATORVASTATIN CALCIUM 51 51 39 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.